Nathan M. Perlmutter serves as Executive at bioAffinity Technologies, Inc., where they oversee executive responsibilities. Since joining the company, Nathan M. Perlmutter has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 6, 2022 involved exercising options for 14,811 shares valued at $100.0K.
Nathan M. Perlmutter currently holds 327,909 shares of bioAffinity Technologies, Inc. (BIAF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nathan M. Perlmutter has been a net neutral trader of BIAF stock. They have purchased $0 and sold $0 worth of shares.
Nathan M. Perlmutter's most recent insider trade was on Sep 6, 2022, when they sold 14,811 shares at $6.75 per share.
Get notified when new Form 4 filings are submitted
| 27,378 |
| $4.20 |
| Discretionary |
| Sep 6, 2022 | BIAF | $369.0K | Conversion | 87,851 | $4.20 | Discretionary |
| Sep 6, 2022 | BIAF | $133.5K | Conversion | 31,780 | $4.20 | Discretionary |